Patients with a hypersensitivity to biphasic insulin aspart 30 or to any of the excipients

Other limiting conditions specified in the locally approved NovoMix 30 SPC ( Summary of Product Characteristics), PIL ( Patient Information Leaflet).

Women who are pregnant, breast feeding or have the intention of becoming pregnant within next couple of months

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes